Markets:

Overview

News

Currencies

International

Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

772.03 -9.57 (-1.22%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Regeneron Pharmaceuticals

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

60 61 Next >

Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space ↗

January 12, 2024

The companies are working on blocking TL1A, a protein tied to inflammatory bowel disease.

Via Investor's Business Daily

Why REGENERON PHARMACEUTICALS (NASDAQ:REGN) qualifies as a quality stock. ↗

January 12, 2024

This article explores why quality investors may have a look at REGENERON PHARMACEUTICALS (NASDAQ:REGN)

Via Chartmill

Could Regeneron Stock Help You Retire a Millionaire? ↗

January 10, 2024

The blossoming biotech might give more than a nudge to investors in this project.

Via The Motley Fool

3 health care stocks off to strong starts in 2024

January 10, 2024

With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers.

Via MarketBeat

Topics Artificial Intelligence

Beyond The Numbers: 13 Analysts Discuss Regeneron Pharmaceuticals Stock ↗

January 09, 2024

Via Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today ↗

January 05, 2024

Via Benzinga

How Is The Market Feeling About Regeneron Pharmaceuticals? ↗

December 27, 2023

Via Benzinga

Unpacking the Latest Options Trading Trends in Regeneron Pharmaceuticals ↗

December 22, 2023

Via Benzinga

Regeneron Slumps As Its Biggest Moneymaker Falls Short; Exelixis Dives On Guidance Woes ↗

January 08, 2024

Shares of both skidded early Monday as the annual J.P. Morgan Healthcare Conferenced kicked off In San Francisco.

Via Investor's Business Daily

3 Top Biotech Stocks Worth Adding To Your Portfolio In 2024 ↗

January 07, 2024

Given the continuous need for innovative medical treatments, the biotech industry may be a haven despite its inherent volatility and an uncertain macroeconomic environment. Here are three top biotech...

Via Talk Markets

Regeneron to Report Fourth Quarter and Full Year 2023 Financial and Operating Results and Host Conference Call and Webcast on February 2, 2024

January 05, 2024

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering ↗

January 05, 2024

Shares soared and then tumbled Friday after the company offered $275 million in public shares.

Via Investor's Business Daily

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Where Will Regeneron Pharmaceuticals Be in 1 Year? ↗

December 22, 2023

Can the stock continue its market-beating ways?

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2024

Via Benzinga

2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More) ↗

January 04, 2024

These innovative biotechs likely aren't done rewarding their shareholders.

Via The Motley Fool

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Records 52-Week High Wednesday Morning

January 03, 2024

Via Investor Brand Network

2 gene-editing stocks reshaping hereditary disease treatments

January 02, 2024

Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal

Via MarketBeat

Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent ↗

December 28, 2023

Wednesday, a court ruling that found Viatris Inc's (NASDAQ:

Via Benzinga

14 Analysts Assess Regeneron Pharmaceuticals: What You Need To Know ↗

December 18, 2023

Via Benzinga

Price Over Earnings Overview: Regeneron Pharmaceuticals ↗

December 18, 2023

Via Benzinga

Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High ↗

December 28, 2023

The market looks set to end 2023 on a high note, but 2024 is less certain, particularly because though, the US does not want further action in the Gulf, it seems, Iran via its proxies is gaming for...

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

Visualized: The Top S&P 500 Stocks Over 20 Years ↗

December 27, 2023

Via Talk Markets

Topics Stocks

7 Undervalued Nasdaq-100 Stocks for Bargain Hunters ↗

December 21, 2023

Though tech innovators blossomed this year, you can still find undervalued deals.

Via InvestorPlace

$1000 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗

December 21, 2023

Via Benzinga

Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

It's Almost 2024: 3 Top Stocks to Buy Before the New Year ↗

December 17, 2023

You can pick these players up for a great price right now.

Via The Motley Fool

AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗

December 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Via InvestorPlace

Topics Artificial Intelligence

3 Stocks to Buy Before 2024 That Can Set You Up For Life ↗

December 14, 2023

These stocks are still relatively cheap, but don't expect them to stay that way for long.

Via The Motley Fool

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.